Diversified Healthcare Trust filed its quarterly report on Form 10-Q with the SEC on November 2, 2026, covering the period ended September 30, 2026, disclosing a net loss of $50,229 thousand for the third quarter and total revenues of $367,670 thousand.

Key Highlights

  • Net loss of $50,229 thousand for the three months ended September 30, 2026, compared to a net loss of $164,040 thousand in the same period of 2025, according to the filing.
  • Total revenues of $367,670 thousand for Q3 2026, down from $388,706 thousand in Q3 2025, with residents fees and services comprising $319,922 thousand of that total.
  • Net loss per common share of $0.21 (basic and diluted) for Q3 2026, versus $0.68 in Q3 2025, on weighted average common shares outstanding of 240,980 thousand.
  • Total assets of $4,189,406 thousand as of September 30, 2026, down from $4,361,250 thousand at December 31, 2025.
  • Total shareholders' equity of $1,529,882 thousand as of September 30, 2026, compared to $1,665,568 thousand at December 31, 2025.
  • Impairment of assets of $14,543 thousand recorded in Q3 2026, a reduction from $93,243 thousand in Q3 2025.
  • 242,563,534 common shares issued and outstanding as of September 30, 2026, per the condensed consolidated balance sheet.

Quarterly Financial Results for Diversified Healthcare Trust, September 30, 2026

Diversified Healthcare Trust (NASDAQ:DHC), a Maryland-based real estate investment trust focused on healthcare properties, reported a net loss of $50,229 thousand for the three months ended September 30, 2026, according to the Form 10-Q filed November 2, 2026. The company's revenues are derived primarily from two sources: rental income, which totaled $47,748 thousand in Q3 2026, and residents fees and services, which totaled $319,922 thousand, for a combined total of $367,670 thousand in the quarter.

Total expenses for the three months ended September 30, 2026 were $382,255 thousand, including property operating expenses of $286,907 thousand, depreciation and amortization of $62,862 thousand, general and administrative costs of $14,643 thousand, acquisition and certain other transaction related costs of $3,300 thousand, and impairment of assets of $14,543 thousand, as reported in the filing. Interest expense for Q3 2026 was $37,164 thousand, which included net amortization of debt discounts, premiums, and issuance costs of $2,306 thousand.

On the balance sheet as of September 30, 2026, the filing reported total real estate properties, net, of $3,717,815 thousand and investments in unconsolidated joint ventures of $122,978 thousand. Total liabilities stood at $2,659,524 thousand, including senior unsecured notes, net, of $1,582,826 thousand and secured debt and finance leases, net, of $454,709 thousand. For the nine months ended September 30, 2026, the company reported a net loss of $130,923 thousand and total revenues of $1,099,528 thousand, the filing disclosed.

What Was Disclosed

Diversified Healthcare Trust's Form 10-Q for the quarter ended September 30, 2026 disclosed a net loss of $50,229 thousand for Q3 2026, total revenues of $367,670 thousand, total assets of $4,189,406 thousand, and shareholders' equity of $1,529,882 thousand, with 242,563,534 common shares issued and outstanding at period end.